News
Grateful after a year of high activity level
Telness Tech
”Industrifonden’s experience in scaling companies globally make them an invaluable partner on our growth journey”.
Martina Klingvall, founder and CEO, Telness Group
EnginZyme
“The long-term support from Industrifonden and their understanding of deep tech is critical for us to disrupt a conservative industry.”
Karim Engelmark Cassimjee, Founder and CEO EnginZyme
Industrifonden is a venture capital fund backing transformative ventures with the power to change the way we live for the better. We look for unique, scalable innovations that have a meaningful impact on our society.
We partner with passionate founders that can turn their ideas into reality and change the industry – or create a totally new one.
Our areas of expertise
The innovators we’ve partnered with
Next generation telecom solutions
Next generation telecom solutions
Telness Tech is a next-generation cloud-based B2B telecom solution for companies looking to enhance innovation capacity while reducing cost and complexity. The product offering consists of an end-to-end Digital Telco on Demand and a White-label Private Branch Exchange (PBX). The company’s flexible and modular telco platform can be deployed and run on any of the major cloud solutions, as well as incumbent IT systems.
Novel treatment for heart failure
Novel treatment for heart failure
Heart failure is the leading cause of hospitalization and death globally. AnaCardio is a biotech company in the clinical stage that is developing a small molecule pharmaceutical with a novel potential first-in-class treatment option. Based on world-leading research from Karolinska Institutet leading to the discovery of a disease-modifying mechanism they provide a unique approach with the potential to save millions of lives.
Electrifying the hydraulics industry
Electrifying the hydraulics industry
Cascade Drives revolutionary technical solution enables energy savings of 60 percent for the global market for hydraulic-based systems. With its patented technology, Cascade Drives dramatically reduces energy consumption and environmental impact, while increasing productivity.
Reprogramming cancer cells to immune cells
Reprogramming cancer cells to immune cells
What if you could reprogram a cancer cell into an immune one? It sounds like science fiction but through years of research, Asgard Therapeutics might have found the solution on how to do just this. The technology is focused on direct cell reprogramming to discover novel approaches for cancer immunotherapy.
Fashion supply chain traceability
Fashion supply chain traceability
TrustTrace’s technology empowers brands and suppliers around the world to standardize how supply chain and material traceability data is captured, digitized, and shared. With all of the trusted supply chain traceability data stored on a single platform, brands get the right evidence in the right place to back-up product claims and meet regulatory compliance.
Memory compression technology
Memory compression technology
Digitalization quickly accelerates energy consumption and maximizing performance per watt in servers and smart devices is critical to breaking the trend. ZeroPoint technology delivers up to 50% higher performance per watt by removing unnecessary information from microchips in data centers and smart devices.
The future of sustainable chemical production
The future of sustainable chemical production
By replacing traditional fossil-based manufacturing of chemicals with a cell-free technology platform, EnginZyme seeks to play a key role in solving one of the fundamental challenges of our time – how to produce better, greener, and cheaper products that we use every day. The cell-free biomanufacturing platform combines the breadth and power of biology and the efficiencies of the chemical industry.
The future of power electronics
The future of power electronics
KISAB is an innovative provider of silicon carbide substrates, striving to define the future of the semiconductor industry. The company has developed a new process for providing silicon carbide substrates at superior cost and quality. This enables the device manufacturers to further push the limits of performance in future power electronics.
Novel treatment for rare conditions
Novel treatment for rare conditions
Calliditas addresses the need of people with rare conditions – starting with treatment for renal and hepatic diseases. Today, Calliditas is the leading pharmaceutical company for treating renal diseases and develops treatment for inflammatory kidney disease as well as for Berger’s disease – the most common form of chronic kidney inflammation.
Industrifonden has made a partial exit of its holding in Calliditas.
Early detection of cancer
Early detection of cancer
Elypta is a diagnostics firm pioneering metabolism-based liquid biopsies. Its technology allows for non-invasive, safe, and cost-effective tests needed for early cancer diagnoses and for patients’ continued monitoring. Starting with kidney cancer, Elypta’s technology is being developed to ultimately be validated across multiple cancers.
